Escitalopram for the Treatment of Depression in Alzheimer's Disease
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
Purpose : to Evaluation of the Efficacy of Escitalopram for the Treatment of Depression in
Alzheimer's Disease
Trial Design : A 12-week, randomized, double-blind, parallel-group, placebo-controlled trial
with an open-label, 12-week extension